|
| 36950806 | Tau Phosphorylation Patterns in the Rat Cerebral Cortex After Traumatic Brain Injury and Sodium Selenate Effects: An Epibios4rx Project 2 Study. | J Neurotrauma | 2024 |
| 36896626 | Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3-WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force. | Epilepsia Open | 2023 |
| 37937383 | Population Pharmacokinetic Model of N-Acetylcysteine During Periods of Recurrent Hypoglycemia in Healthy Volunteers. | Clin Pharmacol Drug Dev | 2023 |
| 37316328 | Levetiracetam Pharmacokinetics and Brain Uptake in a Lateral Fluid Percussion Injury Rat Model. | J Pharmacol Exp Ther | 2023 |
| 36609129 | Why ketamine. | Epilepsy Behav | 2023 |
| 34862270 | Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs. | J Pharmacol Exp Ther | 2022 |
| 33336359 | Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus. | J Clin Pharmacol | 2021 |
| 33742783 | A pharmacokinetic simulation study to assess the performance of a sparse blood sampling approach to quantify early drug exposure. | Clin Transl Sci | 2021 |
| 33567109 | Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial. | Epilepsia | 2021 |
| 33804401 | Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson's Patients, Using In Vivo <sup>31</sup>P MRS-Based Metabolic Imaging at 7T. | Metabolites | 2021 |
| 34275158 | Population Pharmacokinetic Analysis of N-Acetylcysteine in Pediatric Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplant. | J Clin Pharmacol | 2021 |
| 34036177 | Identifying Biological Signatures of N-Acetylcysteine for Non-Suicidal Self-Injury in Adolescents and Young Adults. | J Psychiatr Brain Sci | 2021 |
| 34032604 | Early Neurologic Recovery, Practice Pattern Variation, and the Risk of Endotracheal Intubation Following Established Status Epilepticus. | Neurology | 2021 |
| 34330615 | Characterizing Baclofen Withdrawal: A National Survey of Physician Experience. | Pediatr Neurol | 2021 |
| 32420641 | The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus. | Epilepsia | 2020 |
| 32052462 | Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study. | J Clin Pharmacol | 2020 |
| 32704565 | Infusion of N-acetyl cysteine during hypoglycaemia in humans does not preserve the counterregulatory response to subsequent hypoglycaemia. | Endocrinol Diabetes Metab | 2020 |
| 31161706 | Underdosing of Benzodiazepines in Patients With Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial. | Acad Emerg Med | 2019 |
| 30837282 | Intranasal Coadministration of a Diazepam Prodrug with a Converting Enzyme Results in Rapid Absorption of Diazepam in Rats. | J Pharmacol Exp Ther | 2019 |
| 28940353 | Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress. | J Clin Pharmacol | 2018 |
| 30159892 | Rescue therapies for seizure emergencies: New modes of administration. | Epilepsia | 2018 |
| 27867020 | A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics. | PM R | 2017 |
| 27995128 | Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy. | Front Vet Sci | 2016 |
| 25028414 | A pilot study assessing pharmacokinetics and tolerability of oral and intravenous baclofen in healthy adult volunteers. | J Child Neurol | 2015 |
| 26052837 | Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status. | J Pharm Sci | 2015 |
| 25953073 | Canine status epilepticus treated with fosphenytoin: A proof of principle study. | Epilepsia | 2015 |
| 25952988 | Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus. | Epilepsia | 2015 |
| 24697865 | Pharmacokinetics and pharmacodynamics of intravenous baclofen in dogs: a preliminary study. | J Pharm Pharmacol | 2014 |
| 23962794 | Feasibility study of a caregiver seizure alert system in canine epilepsy. | Epilepsy Res | 2013 |
| 23860343 | N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. | Clin Neuropharmacol | 2013 |
| 22760003 | The role of academic institutions in the development of drugs for rare and neglected diseases. | Clin Pharmacol Ther | 2012 |
| 23018672 | Interaction of N-acetylcysteine and cysteine in human plasma. | J Pharm Sci | 2012 |
| 21955965 | Clinical tolerance and toxicity of intravenous baclofen: a pilot study in a canine model. | J Pediatr Rehabil Med | 2011 |
| 21967357 | Canine status epilepticus: a translational platform for human therapeutic trials. | Epilepsia | 2011 |
| 19116954 | Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. | J Pharm Sci | 2009 |
| 19813763 | Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR). | Mol Pharm | 2009 |